Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$3.09 - $6.0 $4,307 - $8,364
1,394 Added 17.22%
9,491 $50,000
Q4 2023

Feb 02, 2024

BUY
$1.57 - $4.58 $12,426 - $36,250
7,915 Added 4348.9%
8,097 $34,000
Q3 2023

Nov 01, 2023

SELL
$3.14 - $11.2 $1,912 - $6,820
-609 Reduced 76.99%
182 $0
Q2 2023

Aug 04, 2023

BUY
$8.45 - $12.48 $6,683 - $9,871
791 New
791 $8,000
Q4 2022

Feb 02, 2023

SELL
$8.57 - $17.0 $9,735 - $19,312
-1,136 Reduced 19.23%
4,770 $44,000
Q3 2022

Nov 04, 2022

BUY
$12.56 - $17.54 $13,941 - $19,469
1,110 Added 23.14%
5,906 $85,000
Q2 2022

Aug 03, 2022

BUY
$10.55 - $18.81 $50,597 - $90,212
4,796 New
4,796 $63,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.